AU2659900A - Human interleukin 10 mutant proteins - Google Patents

Human interleukin 10 mutant proteins

Info

Publication number
AU2659900A
AU2659900A AU26599/00A AU2659900A AU2659900A AU 2659900 A AU2659900 A AU 2659900A AU 26599/00 A AU26599/00 A AU 26599/00A AU 2659900 A AU2659900 A AU 2659900A AU 2659900 A AU2659900 A AU 2659900A
Authority
AU
Australia
Prior art keywords
human interleukin
mutant proteins
mutant
proteins
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26599/00A
Inventor
Heiner Apeler
Peter Reinemer
Angela Siegling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2659900A publication Critical patent/AU2659900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU26599/00A 1998-11-10 1999-11-04 Human interleukin 10 mutant proteins Abandoned AU2659900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19851675A DE19851675A1 (en) 1998-11-10 1998-11-10 Human interleukin-10 mutant proteins
DE19851675 1998-11-10
PCT/EP1999/008421 WO2000027881A2 (en) 1998-11-10 1999-11-04 Human interleukin 10 mutant proteins

Publications (1)

Publication Number Publication Date
AU2659900A true AU2659900A (en) 2000-05-29

Family

ID=7887222

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26599/00A Abandoned AU2659900A (en) 1998-11-10 1999-11-04 Human interleukin 10 mutant proteins

Country Status (3)

Country Link
AU (1) AU2659900A (en)
DE (1) DE19851675A1 (en)
WO (1) WO2000027881A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3955956A1 (en) 2019-04-19 2022-02-23 Synerkine Pharma B.V. Therapeutic crosslinking of cytokine receptors
CN116209459A (en) * 2020-06-26 2023-06-02 美国安进公司 IL-10 muteins and fusion proteins thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK150596A3 (en) * 1993-07-26 1997-04-09 Schering Corp Agonists and antagonists of human interleukin-10
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues

Also Published As

Publication number Publication date
WO2000027881A2 (en) 2000-05-18
DE19851675A1 (en) 2000-05-11
WO2000027881A3 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
AU4682999A (en) 94 human secreted proteins
AU5134799A (en) 98 human secreted proteins
AU2577799A (en) 45 human secreted proteins
AU5583799A (en) 49 human secreted proteins
AU6552198A (en) 28 human secreted proteins
AU2306499A (en) 110 human secreted proteins
AU3124000A (en) 47 human secreted proteins
AU6952998A (en) 20 human secreted proteins
AU2471899A (en) 67 human secreted proteins
AU2451199A (en) 36 human secreted proteins
AU8066998A (en) 86 human secreted proteins
AU5212299A (en) 71 human secreted proteins
AU9130498A (en) 50 human secreted proteins
AU5928899A (en) 31 human secreted proteins
AU1231400A (en) 12 human secreted proteins
AU8404598A (en) 64 human secreted proteins
AU3006799A (en) 31 human secreted proteins
AU1273499A (en) 148 human secreted proteins
HUP9801681A3 (en) Mutant proteins
AU8921598A (en) 29 human secreted proteins
AU7551494A (en) Human potassium channel 1 and 2 proteins
AU1716200A (en) 31 human secreted proteins
AU2783899A (en) 36 human secreted proteins
AU4906597A (en) Human guanylate-binding proteins
AU2659900A (en) Human interleukin 10 mutant proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase